Carregant...
Chorioretinal Anastomosis for Central Retinal Vein Occlusion: A Review of Its Development, Technique, Complications, and Role in Management
Treatments for central retinal vein occlusion (CRVO) have improved dramatically with the advent of intravitreal agents aimed at blocking the effects of the dominant hypoxia-induced upreglulated cytokine, which is vascular endothelial growth factor (VEGF). This cytokine breaks down the capillary endo...
Guardat en:
| Publicat a: | Asia Pac J Ophthalmol (Phila) |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7299219/ https://ncbi.nlm.nih.gov/pubmed/32501894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/APO.0000000000000286 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|